Field Assessment of the Level of Protection Conferred by a Newly Prepared Combined Inactivated Vaccine against E. co li and P. multo cida in Rabbit in Egypt
- 1 Veterinary Serum and Vaccines Research Institute, Agriculture Research Center, Giza, Egypt
- 2 Veterinary Serum and Vaccines Research Institute, Agriculture Research Center, Giza, Egypt
- 3 Central Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center, Giza, Egypt
- 4 Veterinary Serum and Vaccines Research Institute, Agriculture Research Center, Giza, Egypt
- 5 Central Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center, Giza, Egypt
- 6 Departments of Microbiology, Faculty of Vet Medicine, New Valley University, New Valley, Egypt
- 7 Central Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center, Giza, Egypt
- 8 Central Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center, Giza, Egypt
Abstract
Pasteurellosis is the most prevalent, extremely contagious bacterial disease among domestic rabbits and is considered the leading cause of deaths in rabbits, resulting in enormous economic losses to the rabbit industry. Screening for bacterial agents causing mortalities in rabbits revealed the presence of Enterobacteriacae species in approximately 42% of studied cases, with E. coli the most commonly isolated organism. The present study was designed to evaluate the immune response of rabbits vaccinated with a locally prepared, combined inactivated vaccine of Pasteurella multocida and E. coli , adjuvanated with Montanide ISA70. A total of 370 rabbits, aged 2 - 3 weeks, were divided into four groups: (G1) vaccinated with a polyvalent P. multocida vaccine, (G2) vaccinated with a polyvalent E. coli vaccine, (G3) vaccinated with a combined inactivated Montanide ISA70 vaccine of P. multocida and E. coli , and (G4) kept as a non-vaccinated control group. All rabbits received two doses of 0.5 ml of the prepared vaccines, administered one month apart, and were then challenged with virulent strains of P. multocida and E. coli three weeks after the second vaccination. The prepared vaccines were evaluated by determining humoral immunity using indirect haemagglutination (IHA) test and ELISA. The potency of the vaccines was assessed through challenge and determination of LD50. Experimental findings on the prepared polyvalent combined inactivated P. multocida and E. coli vaccine indicated that it is a potent vaccine, producing the highest antibody titers and a 90% protection rate against challenges with virulent strains of P. multocida type A, D2, and E. coli types O157, O151 and O125. Thus, this vaccine is promising in addressing both P. multocida and E. coli problems in rabbits, farms, providing significant protection, and we recommend its commercial production to help rabbit producers control these two major bacterial infections.
- Mukaila, R. (2022) Agricutural Entrepreneurship among the Youth: The Case of Youth Involvement in Rabbit Production in Nigeria. International Entrepreneurship Review , 8, 35-46. https://doi.org/10.15678/ier.2022.0801.03
- Da Silva, K.G., Borges, T.D., Costa, L.B. and Sotomaior, C.S. (2021) Characteristics of Meat, Pet, and Research Rabbit Farms in Brazil: An Overview Based on Twelve Farms. World Rabbit Science , 29, 115-123. https://doi.org/10.4995/wrs.2021.14125
- Abd El-Ghany, W.A. (2023) Pasteurellosis: A Significant Bacterial Disease in Rabbit Production. Veterinarska stanica , 54, 569-580. https://doi.org/10.46419/vs.54.5.1
- Sharma, A., Sharma, S. and Singh, A.K. (2022) Pasteurellosis in Rabbits. Acta Scientific Veterinary Sciences , 4, 185-187. https://doi.org/10.31080/asvs.2022.04.0485
- Wilson, B.A. and Ho, M. (2013) Pasteurella Multocida : From Zoonosis to Cellular Microbiology. Clinical Microbiology Reviews , 26, 631-655. https://doi.org/10.1128/cmr.00024-13
- Ismail, A.K., Abdien, H.M.F., Hamed, D.M. and El Feil, W.M.K. (2017) Prevalence of Some Enteric Bacterial Infections Causing Rabbit Enteritis and Attempts to Control Rabbit Coli Enteritis with Phytobiotics. Zagazig Veterinary Journal , 45, 91-101. https://doi.org/10.21608/zvjz.2017.29244
- Aboelhadid, S.M., Hashem, S.A., Abdel-Kafy, E.M., Abdel-Baki, A.S., Al-Quraishy, S., Abed, A.H., et al . (2022) Prevalence and Antimicrobial Sensitivity of Escherichia Coli and Salmonella Species in Field Cases of Rabbit Intestinal Coccidiosis Treated with Prebiotic. Austral Journal of Veterinary Sciences , 54, 9-16. https://doi.org/10.4067/s0719-81322022000100009
- Alshimaa, A.M. (2007) Bacteriological Studies on Enteric in Rabbits. Master’s Thesis. Beni-Suef University.
- Tarr, P.I., Gordon, C.A. and Chandler, W.L. (2005) Shiga-Toxin-Producing Escherichia Coli and Haemolytic Uraemic Syndrome. The Lancet , 365, 1073-1086. https://doi.org/10.1016/s0140-6736(05)71144-2
- Ruzauskas, M. (2005) Development and Assay of Inactivated Pasteurella Vaccine for Rabbits. BIOLOGIJA , 51, 35-39.
- El-Jakee, J.K., Moussa, I.M., Omran, M.S., Ahmed, B.M., Elgamal, M.A., Hemeg, H.A., et al . (2020) A Novel Bivalent Pasteurellosis-RHD Vaccine Candidate Adjuvanted with Montanide ISA70 Protects Rabbits from Lethal Challenge. Saudi Journal of Biological Sciences , 27, 996-1001. https://doi.org/10.1016/j.sjbs.2019.12.042